Positive results from moderate-to-severe atopic dermatitis trial
Centessa Pharmaceuticals to be acquired by Lilly
Smart drugs to fight cancer
OpenProtein.AI expands partnership with Boehringer Ingelheim on AI-driven antibody discovery
Ambros Therapeutics launches with $125m to take on complex regional pain syndrome type 1
ADEL and Sanofi sign $1.04bn licence agreement for Alzheimer’s therapy
Aukera Therapeutics emerges from stealth
FDA clears allogeneic CAR-T recurrent glioblastoma therapy for phase II trial
Platform to test new cancer treatments
Potential biomarker for targeted psoriasis therapy discovered
Base to Base biotech podcast 40: Anchored immunotherapy, and healing the skin
Sobi boosts gout battle with Arthrosi Therapeutics acquisition